From FDA to Pharma: Marks' Move to Lilly

From FDA to Pharma: Marks' Move to Lilly

Update: 2025-10-07
Share

Description

From FDA regulator to Big Pharma innovator: Peter Marks' jump to Eli Lilly has the industry buzzing! Discover why his move, influenced by RFK Jr. and following other FDA leaders to giants like Pfizer, is raising eyebrows and sparking debate about the revolving door between public service and private gain. Will Marks' expertise unlock new breakthroughs at Lilly, or will concerns about industry influence take center stage?

Hosted on Acast. See acast.com/privacy for more information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From FDA to Pharma: Marks' Move to Lilly

From FDA to Pharma: Marks' Move to Lilly